AACHEN, Germany--(BUSINESS WIRE)--Aug. 8, 2006--Biopharmaceutical Company PAION (Frankfurt, Prime Standard: PA8) (PA8.DE) today reported that the company will be presenting for the second time at the Banc of America Securities 2006 Specialty Pharmaceuticals Conference in Southampton, NY, on August 10, 2006 at 09:45 AM local time in the Shinnecock Room, at The Southampton Inn. Alexander Vos, Chief Operating Officer of PAION, and Bernhard Hofer, Chief Financial Officer of PAION, will give a review of the company and update the audience on current clinical and business developments, including PAION’s lead PIII product Desmoteplase (INN).
